You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 August 2026 - Israel-based clinical-stage biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF; TASE: CANF), which develops small-molecule drugs for oncological and inflammatory diseases, on Monday reported new preclinical findings s...
17 August 2026 - Biopharmaceutical company Acurx Pharmaceuticals Inc (NASDAQ: ACXP) disclosed on Monday that it has received conditional FDA acceptance for CIFBEZY, the proposed proprietary name for its lead antibiotic candidate ibezapolstat, alongsi...
17 August 2026 - Biopharmaceutical and medical device company Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) on Monday reported preclinical results showing that Aramchol combined with enzalutamide produced a three- to four-fold increase in prostate cancer...
17 August 2026 - Healthcare enterprise platform Azra AI and 4DMedical Limited (ASX: 4DX), a provider of quantitative lung imaging analytics, on Monday announced a strategic OEM and reseller partnership to provide health systems with enterprise-wide l...
17 August 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing Tagrisso (osimertinib) plus Orpathys (savolitinib) delivered statistica...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe